CT and MR cholangiography: Advantages and pitfalls in perioperative evaluation of biliary tree

British Journal of Radiology

Volumn 85, Issue 1015, 2012, Pages 887-896

  Hyodo, Tomoko ^a   Kumano, S ^b   Kushihata, F ^a   Okada, M ^a   Hirata, M ^c   Tsuda, T ^b   Takada, Y ^b   Mochizuki, T ^b   Murakami, T ^a  

^a KINKI UNIVERSITY   (Japan)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c MATSUYAMA RED CROSS HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GADOXETIC ACID; MEGLUMINE IOTROXATE;

BILE DUCT; BILE DUCT CARCINOMA; BILE DUCT INJURY; BILE DUCT MALFORMATION; BILIARY EXCRETION; CHOLANGIOGRAPHY; CHOLECYSTECTOMY; CHOLELITHIASIS; CLINICAL EVALUATION; COMMON BILE DUCT STONE; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC DUCT; HEPATIC DUCT; HEPATOBILIARY SYSTEM; HUMAN; HYPERBILIRUBINEMIA; IMAGE QUALITY; INFUSION CHOLANGIOGRAPHY; INTERMETHOD COMPARISON; INTRAHEPATIC BILE DUCT; LIVER DYSFUNCTION; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; NON INVASIVE MEASUREMENT; OBSTRUCTIVE JAUNDICE; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRURITUS; RADIATION SICKNESS; RASH; REVIEW; THREE DIMENSIONAL IMAGING; URTICARIA;

ADULT; AGED; BILIARY TRACT; BILIARY TRACT DISEASES; BILIARY TRACT NEOPLASMS; CHOLANGIOGRAPHY; CHOLANGIOPANCREATOGRAPHY, MAGNETIC RESONANCE; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PERIOPERATIVE CARE; RADIOGRAPHIC IMAGE ENHANCEMENT; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84863687068     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/21209407     Document Type: Review

References (62)

1. Liu CL, Fan ST, Lo CM, Tso WK, Lam CM, Wong J. Improved operative and survival outcomes of surgical treatment for hilar cholangiocarcinoma. Br J Surg 2006;93:1488-94. (Pubitemid 44893650)
2. Hasegawa S, Ikai I, Fujii H, Hatano E, Shimahara Y. Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications. World J Surg 2007;31:1256-63. (Pubitemid 47029903)
3. Kapoor V, Baron RL, Peterson MS. Bile leaks after surgery. AJR Am J Roentgenol 2004;329:451-8. (Pubitemid 38116591)
4. Suhocki PV, Meyers WC. Injury to aberrant bile ducts during cholecystectomy: a common cause of diagnostic error and treatment delay. AJR Am J Roentgenol 1999;172:955-9. (Pubitemid 29505620)
5. Endo I, Shimada H, Sugita M, Fujii Y, Morioka D, Takeda K, et al. Role of three-dimensional imaging in operative planning for hilar cholangiocarcinoma. Surgery 2007;142:666-75. (Pubitemid 350018849)
6. Hekimoglu K, Ustundag Y, Dusak A, Erdem Z, Karademir B, Aydemir S, et al. MRCP vs. ERCP in the evaluation of biliary pathologies: review of current literature. J Dig Dis 2008;9:162-9.
7. Couinaud C. Surgical anatomy of the liver revisited. Paris, France: Coinaud; 1989. pp. 130-2.
8. Ohkubo M, Nagino M, Kamiya J, Yuasa N, Oda K, Arai T, et al. Surgical anatomy of the bile ducts at the hepatic hilum as applied to living donor liver transplantation. Ann Surg 2004;239:82-6. (Pubitemid 38176376)
9. Kitami M, Takase K, Murakami G, Ko S, Tsuboi M, Saito H, et al. Types and frequencies of biliary tract variations associated with a major portal venous anomaly: analysis with multi-detector row CT cholangiography. Radiology 2006;238:156-66. (Pubitemid 43010592)
10. Cho A, Okazumi S, Yoshinaga Y, Ishikawa Y, Ryu M, Ochiai T. Relationship between left biliary duct system and left portal vein: evaluation with three-dimensional portocholangiography. Radiology 2003;228:246-50. (Pubitemid 36736099)
11. Kawarada Y, Das BC, Onishi H, Taoka H, Gadzijev EM, Ravnik D, et al. Surgical anatomy of the bile duct branches of the medial segment (B4) of the liver in relation to hilar carcinoma. J Hepatobiliary Pancreat Surg 2000;7:480-5.
12. Kitami M, Murakami G, Suzuki D, Takase K, Tsuboi M, Saito H, et al. Heterogeneity of subvesical ducts or the ducts of Luschka: a study using drip-infusion cholangiography-computed tomography in patients and cadaver specimens. World J Surg 2005;29:217-23. (Pubitemid 40576473)
13. Chen JS, Yeh BM, Wang ZJ, Roberts JP, Breiman RS, Qayyum A, et al. Concordance of second-order portal venous and biliary tract anatomies on MDCT angiography and MDCT cholangiography. AJR Am J Roentgenol 2005;184:70-4. (Pubitemid 40040907)
14. Limanond P, Raman SS, Ghobrial RM, Busuttil RW, Lu DS. The utility of MRCP in preoperative mapping of biliary anatomy in adult-to-adult living related liver transplant donors. J Magn Reson Imaging 2004;19:209-15. (Pubitemid 38166798)
15. Gazelle GS, Lee MJ, Mueller PR. Cholangiographic segmental anatomy of the liver. Radiographics 1994;14:1005-13.
16. Cheng YF, Huang TL, Chen CL, Sheen-Chen SM, Lui CC, Chen TY, et al. Anatomic dissociation between the intrahepatic bile duct and portal vein: risk factors for left hepatectomy. World J Surg 1997;21:297-300. (Pubitemid 27100492)
17. Hirao K, Miyazaki A, Fujimoto T, Isomoto I, Hayashi K. Evaluation of aberrant bile ducts before laparoscopic cholecystectomy: helical CT cholangiography versus MR cholangiography. AJR Am J Roentgenol 2000;175:713-20.
18. Murakami T, Kim T, Tomoda K, Narumi Y, Sakon M, Monden M, et al. Aberrant right posterior biliary duct: detection by intravenous cholangiography with helical CT. J Comput Assist Tomogr 1997;21:733-4. (Pubitemid 28049616)
19. Lee VS, Morgan GR, Teperman LW, John D, Diflo T, Pandharipande PV, et al. MR imaging as the sole preoperative imaging modality for right hepatectomy: a prospective study of living adult-to-adult liver donor candidates. AJR Am J Roentgenol 2001;176:1475-82. (Pubitemid 32510267)
20. Lee UY, Murakami G, Han SH. Arterial supply and biliary drainage of the dorsal liver: a dissection study using controlled specimens. Anat Sci Int 2004;79:158-66. (Pubitemid 39232245)
21. Filipponi F, Romagnoli P, Mosca F, Couinaud C. The dorsal sector of human liver: embryological, anatomical and clinical relevance. Hepatogastroenterology 2000;47:1726-31.
22. Kumon M. Anatomy of the caudate lobe with special reference to portal vein and bile duct. Acta Hepat Jan 1985;26:1193-8.
23. Bartlett D, Fong Y, Blumgart LH. Complete resection of the caudate lobe of the liver: technique and results. Br J Surg 1996;83:1076-81. (Pubitemid 26291210)
24. Furukawa H, Sano K, Kosuge T, Shimada K, Yamamoto J, Ishii H, et al. Analysis of biliary drainage in the caudate lobe of the liver: comparison of three-dimensional CT cholangiography and rotating cine cholangiography. Radiology 1997;204:113-17. (Pubitemid 27281717)
25. Murakami G, Hata F. Human liver caudate lobe and liver segment. Anat Sci Int 2002;77:211-24.
26. Wen ZQ, Yan YQ, Yang JM, Wu MC. Precautions in caudate lobe resection: report of 11 cases. World J Gastroenterol 2008;14:2767-70.
27. Yamamoto T, Kubo S, Shuto T, Ichikawa T, Ogawa M, Hai S, et al. Surgical strategy for hepatocellular carcinoma originating in the caudate lobe. Surgery 2004;135:595-603. (Pubitemid 38879342)
28. Takamatsu S, Goseki N, Nakajima K, Teramoto K, Iwai T, Arii S. Distributing pattern of the bile duct of the caudate lobe on computed tomography with drip infusion cholangiography and its surgical significance. Hepatogastroenterology 2004;51:29-32. (Pubitemid 38283054)
29. Turner MA, Fulcher AS. The cystic duct: normal anatomy and disease processes. Radiographics 2001;21:3-22; questionnaire 288-94.
30. Kwon AH, Uetsuji S, Ogura T, Kamiyama Y. Spiral computed tomography scanning after intravenous infusion cholangiography for biliary duct anomalies. Am J Surg 1997;174:396-401; discussion 401-2.
31. Benson EA, Page RE. A practical reappraisal of the anatomy of the extrahepatic bile ducts and arteries. Br J Surg 1976;63:853-60.
32. Okada M, Fukada J, Toya K, Ito R, Ohashi T, Yorozu A. The value of drip infusion cholangiography using multidetector- row helical CT in patients with choledocholithiasis. Eur Radiol 2005;15:2140-5. (Pubitemid 41403512)
33. Mortele KJ, Ros PR. Anatomic variants of the biliary tree: MR cholangiographic findings and clinical applications. AJR Am J Roentgenol 2001;177:389-94. (Pubitemid 32660500)
34. Ko K, Kamiya J, Nagino M, Oda K, Yuasa N, Arai T, et al. A study of the subvesical bile duct (duct of Luschka) in resected liver specimens. World J Surg 2006;30:1316-20. (Pubitemid 44078424)
35. Schroeder T, Radtke A, Kuehl H, Debatin JF, Malago M, Ruehm SG. Evaluation of living liver donors with an allinclusive 3D multi-detector row CT protocol. Radiology 2006;238:900-10. (Pubitemid 43289920)
36. Stockberger SM, Wass JL, Sherman S, Lehman GA, Kopecky KK. Intravenous cholangiography with helical CT: comparison with endoscopic retrograde cholangiography. Radiology 1994;192:675-80. (Pubitemid 24266780)
37. Hashimoto M, Itoh K, Takeda K, Shibata T, Okada T, Okuno Y, et al. Evaluation of biliary abnormalities with 64-channel multidetector CT. Radiographics 2008;28:119-34.
38. Nilsson U. Adverse reactions to iotroxate at intravenous cholangiography. A prospective clinical investigation and review of the literature. Acta Radiol 1987;28:571-5. (Pubitemid 18004834)
39. Persson A, Dahlstrom N, Smedby O, Brismar TB. Three-dimensional drip infusion CT cholangiography in patients with suspected obstructive biliary disease: a retrospective analysis of feasibility and adverse reaction to contrast material. BMC Med Imaging 2006;6:1.
40. Fulcher AS, Turner MA. HASTE MR cholangiography in the evaluation of hilar cholangiocarcinoma. AJR Am J Roentgenol 1997;169:1501-5. (Pubitemid 127469768)
41. Figueras J, Llado L, Valls C, Serrano T, Ramos E, Fabregat J, et al. Changing strategies in diagnosis and management of hilar cholangiocarcinoma. Liver Transpl 2000;6:786-94.
42. Morita S, Saito N, Suzuki K, Mitsuhashi N. Biliary anatomy on 3D MRCP: comparison of volume-rendering and maximum-intensity-projection algorithms. J Magn Reson Imaging 2009;29:601-6.
43. Fulcher AS, Turner MA, Capps GW. MR cholangiography: technical advances and clinical applications. Radiographics 1999;2:25-41, discussion 41-4.
44. Isoda H, Kataoka M, Maetani Y, Kido A, Umeoka S, Tamai K, et al. MRCP imaging at 3.0 T vs. 1.5 T: preliminary experience in healthy volunteers. J Magn Reson Imaging 2007;25:1000-6. (Pubitemid 46697570)
45. Onishi H, Kim T, Hori M, Murakami T, Tatsumi M, Nakaya Y, et al. MR cholangiopancreatography at 3.0 T: intraindividual comparative study withMR cholangiopancreatography at 1.5 T for clinical patients. Invest Radiol 2009;44:559-65.
46. Soto JA, Barish MA, Yucel EK, Siegenberg D, Ferrucci JT, Chuttani R. Magnetic resonance cholangiography: comparison with endoscopic retrograde cholangiopancreatography. Gastroenterology 1996;110:589-97. (Pubitemid 26043894)
47. Carlos RC, Hussain HK, Song JH, Francis IR. Gadoliniumethoxybenzyl- diethylenetriamine pentaacetic acid as an intrabiliary contrast agent: preliminary assessment. AJR Am J Roentgenol 2002;179:87-92. (Pubitemid 34694816)
48. Wallner BK, Schumacher KA, Weidenmaier W, Friedrich JM. Dilated biliary tract: evaluation with MR cholangiography with a T2-weighted contrast-enhanced fast sequence. Radiology 1991;181:805-8.
49. Irie H, Honda H, Kuroiwa T, Yoshimitsu K, Aibe H, Shinozaki K, et al. Pitfalls in MR cholangiopancreatographic interpretation. Radiographics 2001;21:23-37. (Pubitemid 33707407)
50. Watanabe Y, Dohke M, Ishimori T, Amoh Y, Okumura A, Oda K, et al. Pseudo-obstruction of the extrahepatic bile duct due to artifact from arterial pulsatile compression: a diagnostic pitfall of MR cholangiopancreatography. Radiology 2000;214:856-60. (Pubitemid 30115392)
51. Bluemke DA, Sahani D, Amendola M, Balzer T, Breuer J, Brown JJ, et al. Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study. Radiology 2005;237:89-98. (Pubitemid 41346150)
52. Huppertz A, Haraida S, Kraus A, Zech CJ, Scheidler J, Breuer J, et al. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT - initial observations. Radiology 2005;234:468-78. (Pubitemid 40139918)
53. Reimer P, Rummeny EJ, Daldrup HE, Hesse T, Balzer T, Tombach B, et al. Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging. Eur Radiol 1997;7:275-80. (Pubitemid 127538595)
54. Vogl TJ, Kummel S, Hammerstingl R, Schellenbeck M, Schumacher G, Balzer T, et al. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 1996;200:59-67. (Pubitemid 26197732)
55. Kogita S, Imai Y, Okada M, Kim T, Onishi H, Takamura M, et al. Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow. Eur Radiol 2010;20:2405-13.
56. Bollow M, Taupitz M, Hamm B, Staks T, Wolf KJ, Weinmann HJ. Gadolinium-ethoxybenzyl-DTPA as a hepatobiliary contrast agent for use in MR cholangiography: results of an in vivo phase-I clinical evaluation. Eur Radiol 1997;7:126-32. (Pubitemid 127538537)
57. Tschirch FT, Struwe A, Petrowsky H, Kakales I, Marincek B, Weishaupt D. Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma. Eur Radiol 2008;18:1577-86.
58. Seale MK, Catalano OA, Saini S, Hahn PF, Sahani DV. Hepatobiliary- specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics 2009;29:1725-48.
59. Lee NK, Kim S, Lee JW, Lee SH, Kang DH, Kim GH, et al. Biliary MR imaging with Gd-EOB-DTPA and its clinical applications. Radiographics 2009;29:1707-24.
60. Schuhmann-Giampieri G, Schmitt-Willich H, Frenzel T, Schitt-Willich H. Biliary excretion and pharmacokinetics of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging in the rat. J Pharm Sci 1993;82:799-803. (Pubitemid 23314085)
61. Reimer P, Schneider G, Schima W. Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications. Eur Radiol 2004;14:559-78. (Pubitemid 38444568)
62. Zech CJ, Herrmann KA, Reiser MF, Schoenberg SO. MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA. Magn Reson Med Sci 2007;6:43-52.